… In this study, incorporation of CsA into cationic chitosan nanoparticles was planned with an
attempt to increase the ophthalmic contact time of CsA with the help of molecular attraction of …

… from the chitosan/TPP-hyaluronic acid nanoparticles gel formulation. … chitosan/TPP-hyaluronic
acid nanoparticle eye drop formulations are a promising platform for ocular drug delivery …

… In the following section, we will report in detail the characteristics and the in vivo behaviour
of chitosan nanoparticles (CS NP) as ocular delivery systems for the treatment of diseases …

… long-term extraocular drug delivery without compromising intraocular structures … of chitosan
(CS) nanoparticles as a new vehicle for the improvement of the delivery of drugs to the ocular …

… To assess the potential of chitosan (CS) nanoparticles for ocular drug delivery by investigating
their interaction with the ocular mucosa in vivo and also their toxicity in conjunctival cell …

… of chitosan nanoparticles with improved characteristics. CSNPs were prepared using the
chitosan … chitosan solution by centrifugation. These CSNPs have been shown to be a good drug …

… potential upon incubation of chitosan nanoparticles in the presence of … chitosan nanoparticles.
Therefore, the conclusions from this study were that the stability of chitosan nanoparticles …

… chitosan-nanoparticles (CSNPs) for ocular delivery of tedizolid phosphate (TZP) for the
treatment of MRSA-related ocular … Physicochemical characterizations were performed for ocular …

… to deliver drugs to the ocular surface. This nanosystem, liposome–chitosan nanoparticle …
-NP), was created as a complex between liposomes and chitosan nanoparticles (CS-NP). The …

… chitosan nanoparticles were prepared for encapsulation of daptomycin, as an alternative
therapy for the treatment of ocular … The obtained nanoparticles have appropriate characteristics …